Inovio Pharmaceuticals Inc (NAS:INO)
$ 4.19 0.18 (4.49%) Market Cap: 109.36 Mil Enterprise Value: 37.00 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 46/100

Inovio Pharmaceuticals Inc Presenting at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 01:30PM GMT
Release Date Price: $75.6 (-2.93%)
Aspen Mori
BofA Securities, Research Division - Associate

Good morning, everyone, and welcome to day 2 of the BofA Virtual Vegas Health Care Conference. My name is Aspen Mori. I am an associate on the large-cap biopharma team. And I'm joined today by my team, Alex Hammond. And we're lucky to be speaking today to Inovio's CEO, Joseph Kim. Joseph, how are you doing today?

J. Joseph Kim
Inovio Pharmaceuticals, Inc. - CEO, President & Director

Great to be here. Thank you, Aspen.

Aspen Mori;J. Joseph Kim
BofA Securities, Research Division - Associate;Inovio Pharmaceuticals, Inc. - CEO, President

Great. So I'm thinking today, we'll kind of try and run through as many programs as Inovio has in the clinic right now. But maybe we start off a little bit high level and you could just talk about how Inovio is dealing with the pandemic these days. Any lingering impacts to your underlying business, thinking about regulatory interactions, clinical trial operations, anything along those lines?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot